ASLAN Pharmaceuticals Ltd. Upgraded to Buy Heres Why - Yahoo Movies UK

ASLNDelisted Stock  USD 0.60  0.03  4.76%   
About 62% of Aslan Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Aslan Pharmaceuticals suggests that many traders are alarmed regarding Aslan Pharmaceuticals' prospects. Aslan Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Aslan Pharmaceuticals. Many technical investors use Aslan Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
ASLAN Pharmaceuticals Ltd. Upgraded to Buy Heres Why Yahoo Movies UK

Read at news.google.com
Google News at Macroaxis
  

Aslan Pharmaceuticals Fundamental Analysis

We analyze Aslan Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aslan Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aslan Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Target Price

Target Price Comparative Analysis

Aslan Pharmaceuticals is currently under evaluation in target price category among its peers.

Aslan Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aslan Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Aslan Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Aslan Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Aslan Pharmaceuticals Related Equities

NAMSNewAmsterdam Pharma   41.41   
0%
100.0%
ACRVAcrivon Therapeutics,   8.45   
0%
20.0%
CMPXCompass Therapeutics   7.88   
0%
19.0%
LYRALyra Therapeutics   5.00   
0%
12.0%
ANTXAN2 Therapeutics   2.65   
0%
6.0%
ANEBAnebulo Pharmaceuticals   0.64   
0%
1.0%
CGEMCullinan Oncology   0.24   
1.0%
0%
IVAInventiva   0.38   
1.0%
0%
ERASErasca   0.67   
1.0%
0%
AVTEAerovate Therapeutics   1.14   
2.0%
0%
GPCRStructure Therapeutics   1.30   
3.0%
0%
MLYSMineralys Therapeutics,   1.45   
3.0%
0%
CTMXCytomX Therapeutics   2.48   
5.0%
0%
ACHLAchilles Therapeutics   2.86   
6.0%
0%
IOBTIO Biotech   4.55   
10.0%
0%
AGIOAgios Pharm   5.76   
13.0%
0%
ASMBAssembly Biosciences   6.46   
15.0%
0%
TILInstil Bio   7.12   
17.0%
0%
GLUEMonte Rosa   9.85   
23.0%
0%
ADAGAdagene   16.21   
39.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Aslan Stock

If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Transaction History
View history of all your transactions and understand their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets